Research.Patient.info

Spinocerebellar Ataxia type-3 (SCA3) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingPhase II and Phase III (Integrated)
A DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TRIAL TO ASSESS SAFETY AND EFFICACY OF SLS-005 (TREHALOSE INJECTION, 90.5 MG/ML FOR INTRAVENOUS INFUSION) FOR THE TREATMENT OF ADULTS WITH SPINOCEREBELLAR ATAXIA
This study is testing a new medicine, SLS-005, for adults with a condition called Spinocerebellar Ataxia type-3 (SCA3). Researchers want to see if it improves movement and daily activities, and if it's safe to use.
Spain · Portugal · Germany